Blakeley Hamit
Family · Norman, OKNPI 1982140349
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $559, 2.1 times the $271 reported in 2021.
Across 95 payments — averaging $21.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$441
- Pfizer$279
- Ironshore Pharmaceuticals Inc.$242
- Corium, LLC$149
- Merck$141
- Sobi, Inc$99
- plus $677 from 19 others
What the payments were for
- Food & beverage$2,029100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 11 | $441 |
| Pfizer | 16 | $279 |
| Ironshore Pharmaceuticals Inc. | 7 | $242 |
| Corium, LLC | 9 | $149 |
| Merck | 8 | $141 |
| Sobi, Inc | 6 | $99 |
| Collegium Pharmaceutical, Inc. | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| Sanofi Pasteur Inc. | 4 | $77 |
| AstraZeneca | 3 | $67 |
| Cranial Technologies, Inc | 3 | $47 |
| Seqirus USA Inc | 2 | $41 |
| Vertical Pharmaceuticals, LLC | 2 | $35 |
| Kaleo, Inc. | 2 | $34 |
| UCB, Inc. | 2 | $33 |
| GSK | 2 | $28 |
| Galderma Laboratories, L.p. | 2 | $28 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Alk-abello, Inc | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Biomarin Pharmaceutical Inc. | 1 | $15 |
| Sage Therapeutics, LLC | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,029 in reported general payments places this provider in the 80th percentile of 2,026 family providers in Oklahoma.
Other family in Norman
- Katherine BuckNorman$14K
- Jackson LaizureNorman$13K
- Jordan HarrisNorman$12K
- Julie RobersonNorman$10K
- April WilcoxOklahoma City$245K
- Jeremy MorganOklahoma City$63K
- Samantha BellingerOklahoma City$39K
- Candy WilliamsTulsa$22K
- Lacey HillOklahoma City$20K
- Shelby WrightStillwater$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.